Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Alverine
2. Alverine Hydrochloride
3. Spasmaverine
4. Spasmonal
1. 5560-59-8
2. Alverine (citrate)
3. Antispasmin
4. Spacolin
5. Gamatran Citrate
6. Nsc 35459
7. Spasmaverine
8. Alverine Citrate Salt
9. Calmabel
10. Profenine
11. Prophelan
12. Proverine
13. Profenil Citrate
14. Nci 85x
15. Alverine Citrate [usan]
16. Nsc-35459
17. Phenpropamine Citrate
18. N-ethyl-3,3'-diphenyldipropylamine Citrate (1:1)
19. 9jfb58yk1e
20. Mls000069524
21. 5560-59-8 (citrate)
22. Chebi:53785
23. N-ethyl-3-phenyl-n-(3-phenylpropyl)propan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate
24. Dipropylamine, N-ethyl-3,3'-diphenyl-, Citrate (1:1)
25. Ncgc00017047-01
26. Smr000058631
27. Cas-5560-59-8
28. Alverine Citrate (usan)
29. Benzenepropanamine, N-ethyl-n-(3-phenylpropyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
30. Dsstox_cid_25562
31. Dsstox_rid_80959
32. Dsstox_gsid_45562
33. Alverine Dihydrogen Citrate
34. N-ethyl-3-phenyl-n-(3-phenylpropyl)propan-1-amine;2-hydroxypropane-1,2,3-tricarboxylic Acid
35. Sr-01000003029
36. Unii-9jfb58yk1e
37. Alverine Citrate [usan:nf]
38. Prestwick_912
39. Einecs 226-929-3
40. Alverinecitrate
41. Opera_id_1477
42. Dipropylamine, N-ethyl-3,3'-diphenyl-, Citrate
43. N-ethyl-bis(3-phenylpropyl)amin-dihydrogencitrat
44. Mls001148462
45. Mls002207301
46. Mls002222279
47. Mls004712036
48. Alverine Citrate [mi]
49. Schembl352008
50. Spectrum1500109
51. Regid_for_cid_21718
52. Chembl1408594
53. Dtxsid3045562
54. Alverine Citrate [mart.]
55. Alverine Citrate [who-dd]
56. Hms1568d09
57. Hms1920a17
58. Hms2091g17
59. Hms2095d09
60. Hms2232d03
61. Hms3371i14
62. Hms3651f18
63. Hms3712d09
64. Hms3885o05
65. Pharmakon1600-01500109
66. Hy-b0500
67. Tox21_110757
68. Dipropylamine,3'-diphenyl-, Citrate
69. Mfcd00035086
70. Nsc755859
71. S3054
72. Akos015895657
73. Tox21_110757_1
74. Alverine Citrate [ep Monograph]
75. Ccg-212472
76. Nsc-755859
77. Ncgc00017047-02
78. Ncgc00017047-03
79. Ncgc00021122-08
80. Ncgc00094581-01
81. Ncgc00094581-02
82. As-56723
83. Db-052764
84. N-ethyl-3,3'-diphenyldipropylamine Citrate
85. Dipropylamine,3'-diphenyl-, Citrate (1:1)
86. Ft-0622247
87. Sw197030-3
88. A16396
89. D02877
90. D84224
91. A830720
92. Sr-01000003029-2
93. Sr-01000003029-4
94. Q27124210
95. Benzenepropanamine, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
96. Citric Acid; N-ethyl-3-phenyl-n-(3-phenylpropyl)propan-1-amine
97. 2-hydroxypropane-1,2,3-tricarboxylic Acid; Ethylbis(3-phenylpropyl)amine
98. Alverine Citrate Salt, European Pharmacopoeia (ep) Reference Standard
99. Alverine For Peak Identification, European Pharmacopoeia (ep) Reference Standard
Molecular Weight | 473.6 g/mol |
---|---|
Molecular Formula | C26H35NO7 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 14 |
Exact Mass | 473.24135246 g/mol |
Monoisotopic Mass | 473.24135246 g/mol |
Topological Polar Surface Area | 135 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 442 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29917
Submission : 2015-10-06
Status : Inactive
Type : II
Registrant Name : Sungwoo Chemical Co., Ltd.
Registration Date : 2023-04-12
Registration Number : 20201207-211-J-574(1)
Manufacturer Name : Procos SPA
Manufacturer Address : Via.Matteotti, 249, 28062 Cameri(NO), Italy
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Alvercol
Dosage Form : GRA
Dosage Strength : 2g/10g
Packaging : 200X1g/10g
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Alvercol
Dosage Form : GRA
Dosage Strength : 2g/10g
Packaging : 500X1g/10g
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info :
Registration Country : Vietnam
Brand Name : SPASMABOSTON 60
Dosage Form : Hard Capsule
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Vietnam
Packaging :
Regulatory Info :
Dosage : Hard Capsule
Dosage Strength : 60MG
Brand Name : SPASMABOSTON 60
Approval Date :
Application Number :
Registration Country : Vietnam
Regulatory Info :
Registration Country : Turkey
Brand Name : SIMESPASMIL
Dosage Form : SOFT CAPSULE
Dosage Strength : 60MG; 300MG
Packaging : 20 OR 40 CAPSULES
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging : 20 OR 40 CAPSULES
Regulatory Info :
Dosage : SOFT CAPSULE
Dosage Strength : 60MG; 300MG
Brand Name : SIMESPASMIL
Approval Date :
Application Number :
Registration Country : Turkey
Market Place
Reply
17 Aug 2023
Reply
03 Aug 2023
Reply
10 Oct 2022
Reply
18 Jun 2022
Reply
23 Jul 2019
REF. STANDARDS & IMPURITIES
Alverine citrate
CAS Number : 5560-59-8
Quantity Per Vial : 5 mg
Sale Unit : 1
Order Code : Y0000687
Batch No : 1
Price (€) : 79
Storage : +5°C ± 3°C
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?